Efficacy of omalizumab in severe chronic spontaneous urticaria: Real life data from a Greek tertiary center

Dermatol Ther. 2018 Nov;31(6):e12739. doi: 10.1111/dth.12739. Epub 2018 Nov 5.
No abstract available

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Anti-Allergic Agents / adverse effects
  • Anti-Allergic Agents / therapeutic use*
  • Chronic Disease
  • Female
  • Greece
  • Humans
  • Male
  • Middle Aged
  • Omalizumab / adverse effects
  • Omalizumab / therapeutic use*
  • Prospective Studies
  • Remission Induction
  • Severity of Illness Index
  • Skin / drug effects*
  • Skin / immunology
  • Skin / pathology
  • Treatment Outcome
  • Urticaria / diagnosis
  • Urticaria / drug therapy*
  • Urticaria / immunology

Substances

  • Anti-Allergic Agents
  • Omalizumab